Area of research
Oncology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Oncology, Hazard ratio, Internal medicine, Metastatic breast cancer, and Triple-negative breast cancer.
ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer
A phase Ib study of PI3Kα inhibitor risovalisib mesylate in combination with fulvestrant in patients with <i>PIK3CA</i>-mutated, HR+/HER2- advanced breast cancer.
ARX788 Versus Lapatinib Plus Capecitabine in the Second-Line Treatment of HER2-Positive Advanced Breast Cancer (ACE-Breast-02): A Multicentre, Open-Label, Phase III, Randomised Controlled Trial
Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors
X-ray measurement of metacarpal and phalange bones in the right hand of population in Kaschin-Beck disease regions, Qinghai Province